posted on 2018-01-09, 14:05authored byYi-Juan Hu, Amand F. Schmidt, Frank Dudbridge, Michael V. Holmes, James M. Brophy, Vinicius Tragante, Ziyi Li, Peizhou Liao, Arshed A. Quyyumi, Raymond O. McCubrey, Benjamin D. Horne, Aroon D. Hingorani, Folkert W. Asselbergs, Riyaz S. Patel, Qi Long
BACKGROUND: Studies of recurrent or subsequent disease events may be susceptible to bias caused by selection of subjects who both experience and survive the primary indexing event. Currently, the magnitude of any selection bias, particularly for subsequent time-to-event analysis in genetic association studies, is unknown. METHODS AND RESULTS: We used empirically inspired simulation studies to explore the impact of selection bias on the marginal hazard ratio for risk of subsequent events among those with established coronary heart disease. The extent of selection bias was determined by the magnitudes of genetic and nongenetic effects on the indexing (first) coronary heart disease event. Unless the genetic hazard ratio was unrealistically large (>1.6 per allele) and assuming the sum of all nongenetic hazard ratios was <10, bias was usually <10% (downward toward the null). Despite the low bias, the probability that a confidence interval included the true effect decreased (undercoverage) with increasing sample size because of increasing precision. Importantly, false-positive rates were not affected by selection bias. CONCLUSIONS: In most empirical settings, selection bias is expected to have a limited impact on genetic effect estimates of subsequent event risk. Nevertheless, because of undercoverage increasing with sample size, most confidence intervals will be over precise (not wide enough). When there is no effect modification by history of coronary heart disease, the false-positive rates of association tests will be close to nominal.
Funding
This study was supported by the National Institutes of Health (R01GM116065 and R03AI111396 to Dr Hu, R03CA173770, R03CA183006, and R21NS091630 to Dr Long); University College London (UCL) Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (BRC10200 to Dr Schmidt and Dr Hingorani [Dr Hingorani is NIHR Senior Investigator], BRC169529 to Dr Asselbergs); UCL Springboard Population Health Sciences fellowship (to Dr Schmidt); Medical Research Council (MR/K006215/1 to Dr Dudbridge); a Dekker scholarship of Netherlands Heart Foundation (Junior Staff Member 2014T001 to Dr Asselbergs); and a British Heart Foundation Intermediate Fellowship (FS/14/76/30933 to Dr Patel).
The file associated with this record is under embargo until 6 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.